Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 7673104)

1.

Difference of the naltrexone's effects in social drinkers by spicy food preference.

Lee JS, Kim SG, Jeong HJ, Kim JH, Yang YH, Jung WY.

J Korean Med Sci. 2014 May;29(5):714-8. doi: 10.3346/jkms.2014.29.5.714. Epub 2014 Apr 25.

2.

Pharmacological approaches to reducing craving in patients with alcohol use disorders.

Haass-Koffler CL, Leggio L, Kenna GA.

CNS Drugs. 2014 Apr;28(4):343-60. doi: 10.1007/s40263-014-0149-3. Review.

3.

Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time.

Del Re AC, Maisel N, Blodgett JC, Wilbourne P, Finney JW.

J Clin Psychopharmacol. 2013 Oct;33(5):649-57. doi: 10.1097/JCP.0b013e3182983e73. Review.

4.

Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW.

Addiction. 2013 Feb;108(2):275-93. doi: 10.1111/j.1360-0443.2012.04054.x. Epub 2012 Oct 17. Review.

5.

Maintenance medication for opiate addiction: the foundation of recovery.

Bart G.

J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598. Review.

6.

Dihydrocodeine/Agonists for alcohol dependents.

Ulmer A, Müller M, Frietsch B.

Front Psychiatry. 2012 Mar 23;3:21. doi: 10.3389/fpsyt.2012.00021. eCollection 2012.

7.

Age at onset typology in opioid dependent men: an exploratory study.

De B, Mattoo SK, Basu D.

Indian J Psychiatry. 2002 Apr;44(2):150-60.

8.

Pharmacoprophylaxis of alcohol dependence: Review and update Part II: Efficacy.

Grover S, Basu D, Bhateja G.

Indian J Psychiatry. 2007 Jan;49(1):26-33. doi: 10.4103/0019-5545.31515.

9.

Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.

Garbutt JC, Osborne M, Gallop R, Barkenbus J, Grace K, Cody M, Flannery B, Kampov-Polevoy AB.

Alcohol Alcohol. 2009 May-Jun;44(3):293-300. doi: 10.1093/alcalc/agn122. Epub 2009 Feb 3.

10.

GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse.

Carnicella S, Kharazia V, Jeanblanc J, Janak PH, Ron D.

Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8114-9. doi: 10.1073/pnas.0711755105. Epub 2008 Jun 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk